Radio and PodcastRadio and PodcastLive Radio & Podcasts
Fremanezumab for the Treatment of Migraine and Major Depressive Disorder artwork
Science & Medicine

Fremanezumab for the Treatment of Migraine and Major Depressive Disorder

JAMA Neurology Author Interviews: Covering research, science, & clinical practice in the structure and function of the nervous system by American Medical Association

May 5, 202521:13Science & Medicine

Interview with Richard B. Lipton, MD, author of Fremanezumab for the Treatment of Patients With Migraine and Comorbid Major Depressive Disorder. Hosted by Cynthia E. Armand, MD. Related Content: Fremanezumab for the Trea...

About This Episode

Fremanezumab for the Treatment of Migraine and Major Depressive Disorder is an episode from JAMA Neurology Author Interviews: Covering research, science, & clinical practice in the structure and function of the nervous system by American Me...

Podcast

This episode belongs to JAMA Neurology Author Interviews: Covering research, science, & clinical practice in the structure and function of the nervous system.

Listen Online

Use the player on this page to stream the episode online.

Episode Details

Published May 5, 2025, 21:13 long, audio available.

Related Episodes

Continue listening to more episodes from JAMA Neurology Author Interviews: Covering research, science, & clinical practice in the structure and function of the nervous system.

Questions About This Episode

What is Fremanezumab for the Treatment of Migraine and Major Depressive Disorder about?

Interview with Richard B. Lipton, MD, author of Fremanezumab for the Treatment of Patients With Migraine and Comorbid Major Depressive Disorder. Hosted by Cynthia E. Armand, MD. Related Content: Fremanezumab for the Treatment of Patients With Migraine and Comorbid Major Depressive Disorder

Where can I listen to Fremanezumab for the Treatment of Migraine and Major Depressive Disorder?

You can listen to Fremanezumab for the Treatment of Migraine and Major Depressive Disorder online on Radio and Podcast. Open the player on this page to stream the available audio.

Which podcast is Fremanezumab for the Treatment of Migraine and Major Depressive Disorder from?

Fremanezumab for the Treatment of Migraine and Major Depressive Disorder is an episode from JAMA Neurology Author Interviews: Covering research, science, & clinical practice in the structure and function of the nervous system by American Medical Association.

How long is this episode?

This episode is 21:13 long.

When was this episode published?

This episode was published on May 5, 2025.

Can I save Fremanezumab for the Treatment of Migraine and Major Depressive Disorder for later?

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Are there related episodes from JAMA Neurology Author Interviews: Covering research, science, & clinical practice in the structure and function of the nervous system?

Yes. This page shows related episodes from JAMA Neurology Author Interviews: Covering research, science, & clinical practice in the structure and function of the nervous system when more episodes are available from the podcast feed.

Quick Answers About This Episode

Where can I listen to Fremanezumab for the Treatment of Migraine and Major Depressive Disorder?

You can listen to Fremanezumab for the Treatment of Migraine and Major Depressive Disorder on this page when the episode audio is available from the podcast feed.

Which podcast is this episode from?

Fremanezumab for the Treatment of Migraine and Major Depressive Disorder is from JAMA Neurology Author Interviews: Covering research, science, & clinical practice in the structure and function of the nervous system by American Medical Association.

What are the episode details?

Published May 5, 2025 and 21:13 long